WSGR – Free Expert Articles


Free Expert Articles & Resources

– Patenting Biosimilars
– Opportunities & Challenges of Biosimilars
– Complexity of Biosimilars
– Cost of Biosimilars
– Partnering & Alliances in Biosimilars  

Download Form

First Name*

Last Name*

Email Address


Job Title*


Company Type*

Download Free Expert Legal Articles from Wilson Sonsini Goodrich Rosati


You will learn about:

• Biologics Regulatory Pathways in the United States and Europe
• Hatch-Waxman Generics/Biosimilar Legislation
• The Biologics Act (BPCI) • European Medicines Agency (EMA) Biosimilar Regulation
• Current Status of Biosimilar Proceedings • Originator Tactics to Derail Biosimilars
• The Impact of Regulation & Distribution Channels

In addition, you will receive the complete set of content outlined above the form. The finest possible introduction to all the major issues facing biosimilars.

Fill out the form to receive content immediately.

Who are Wilson Sonsini Goodrich & Rosati?

WSGR is the premier legal advisor to technology, life sciences, and other growth enterprises worldwide. We represent companies at every stage of development, from entrepreneurial start-ups to multibillion-dollar global corporations, as well as the venture firms, private equity firms, and investment banks that finance and advise them.

The firm’s broad range of services and practice areas are focused on addressing the principal challenges faced by the management, boards of directors, shareholders, and in-house counsel of our clients.

Global Generics

In today’s fast-growing, highly regulated generic pharmaceutical market, companies increasingly require specialized legal guidance as their products are developed, launched, and litigated. Wilson Sonsini Goodrich & Rosati’s interdisciplinary global generics practice was created specifically to address this need, and provides sophisticated representation far beyond the scope of general corporate and securities counsel.

We have assembled a highly experienced team of experts from a cross-section of the firm’s key practice areas, including intellectual property, litigation, antitrust, FDA/regulatory, technology transactions, export controls and FCPA, trade secrets and employee mobility, and trademarks, copyrights, and advertising.

The members of the firm’s global generics practice, led by the former chief legal officer of Mylan Pharmaceuticals, one of the world’s leading generic and specialty pharmaceutical companies, work closely with our generic pharmaceutical clients’ legal and scientific personnel and senior management to understand and meet their specific needs both in the U.S. and abroad. Our attorneys, many of whom previously served as in-house general counsel of life sciences companies, possess a deep understanding of the complex international regulatory landscape, particularly as it pertains to life sciences, medical device, and pharmaceutical companies in the rapidly growing Chinese, Indian, and European markets.